88
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France

, , , , , , , , & show all
Pages 1159-1169 | Published online: 10 Jul 2017

References

  • Panel on Antiretroviral Guidelines for Adults and AdolescentsGuidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services Available from: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdfAccessed April 11, 2016
  • MorlatPPrise en charge médicale des personnes vivant avec le VIH. Recommandations du groupe d’experts – Rapport 2013. Sous la direction du Pr Philippe Morlat et sous l’égide du CNS et de l’ANRS [Medical care of people living with HIV. Expert group recommendations – 2013 report] Available from: http://www.sante.gouv.fr/IMG/pdf/Rapport_Morlat_2013_Mise_en_ligne.pdfAccessed April 11, 2016 French
  • DelfraissyJFPrise en charge des personnes infectées par le VIH: Recommandations du groupe d’experts – 2002 [Medical care of people living with HIV. Expert group recommendations – 2002 report] Available from: http://www.ladocumentationfrancaise.fr/var/storage/rapports-publics/034000460.pdfAccessed April 11, 2016 French
  • TurnerBJAdherence to antiretroviral therapy by human immunodeficiency virus-infected patientsJ Infect Dis2002185Suppl 2S143S15112001036
  • AmmassariAMurriRPezzottiPSelf-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infectionJ Acquir Immune Defic Syndr200128544544911744832
  • PatersonDLSwindellsSMohrJAdherence to protease inhibitor therapy and outcomes in patients with HIV infectionAnn Intern Med20001331213010877736
  • LangebeekNGisolfEHReissPPredictors and correlates of adherence to antiretroviral therapy (ART) for chronic HIV infection: a meta-analysisBMC Med20141214225145556
  • BeusterienKMDavisEAFloodRHowardKJordanJHIV patient insight on adhering to medication: a qualitative analysisAIDS Care200820224425218293136
  • ConwayBThe role of adherence to antiretroviral therapy in the management of HIV infectionJ Acquir Immune Defic Syndr200745Suppl 1S14S1817525686
  • StoneVEJordanJTolsonJMillerRPilonTPerspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherenceJ Acquir Immune Defic Syndr200436380881615213564
  • MoyleGThe assessing patients’ preferred treatments (APPT-1) studyInt J STD AIDS200314Suppl 1343614617402
  • Al-DakkakIPatelSMcCannEGadkariAPrajapatiGMaieseEMThe impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysisAIDS Care201325440041422908886
  • LamiraudKMoattiJPRaffiFAdherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationshipMed Care201250541041822362167
  • CohenCJMeyersJLDavisKLAssociation between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIVBMJ Open201338e003028
  • ParientiJJBangsbergDRVerdonRGardnerEMBetter adherence with once-daily antiretroviral regimens: a meta-analysisClin Infect Dis200948448448819140758
  • DeJesusEYoungBMorales-RamirezJOSimplification of antiretroviral therapy to a single tablet regimen consisting of efavirenz, emtracitabine and tenofavir disoproxil fumarate versus unmodified antiretroviral therapy in a virologically suppressed HIV-1 infected patientsJ Acquir Immune Defic Syndr200951216317419357529
  • HodderSLMounzerKDeJesusEPatient-reported outcomes in virologically suppressed, HIV-1 infected subjects after switching to a simplified, single tablet regimen of efavirenz, emtricitabine and tenofovir DFAIDS Patient Care STDS2010242115125
  • AirioldiMZaccarelliMBisiLOne-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjectsPatient Prefer Adherence2010411512520517472
  • CookJAGreyDDBurke-MillerJKIllicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenDrug Alcohol Depend2007891748117291696
  • FieldsELBogartLMThurstonIBQualitative comparison of barriers to antiretroviral medication adherence among perinatally and behaviorally HIV-infected youthconference: Society for Adolescent Health and Medicine Annual Meeting: Impact of Trauma on Teens: Building the Safety Net 2012New Orleans, LA United States2012 Available from: http://www.iapac.org/AdherenceConference/presentations/ADH6_69948.pptAccessed July 20, 2015
  • PowerRKoopmanCVolkJSocial support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected personsAIDS Patient Care STDS200317524525212816618
  • KellyDJHartmanCGrahamJKallenMAGiordianoTPSocial support as a predictor of early diagnosis, linkage, retention and adherence to HIV care: results from The Steps StudyJ Assoc Nurses AIDS Care201425540541324508174
  • CatzSLKellyJABogartLMBenotschEGMcAuliffeTLPatterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV diseaseHealth Psychol200019212413310762096
  • KatzITRyuAEOnuegbuAGImpact of HIV-related stigma on treatment adherence: systematic review and meta-synthesisJ Int AIDS Soc2013163 Suppl 21864024242258
  • IngersollKSHeckmanCJPatient-clinician relationships and treatment system effects on HIV medication adherenceAIDS Behav2005918910115812616
  • FlickingerTESahaSMooreRDBeachMCHigher quality communication and relationships are associated with improved patient engagement in HIV careJ Acquir Immune Defic Syndr201363336236623591637
  • KalichmanSCPopeHWhiteDAssociation between health literacy and HIV treatment adherence: further evidence from objectively measured medication adherenceJ Int Assoc Physicians AIDS Care200876317323
  • KremerHIronsonGPorrMSpiritual and mind-body beliefs as barriers and motivators to HIV-treatment decision-making and medication adherence? A qualitative studyAIDS Patient Care STDS200923212713419133751
  • BeusterienKMDziekanKFloodEHardingGJordanJCUnderstanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessmentValue Health20058445346116091022
  • LancsarELouviereJConducting discrete choice experiments to inform healthcare decision making: a user’s guidePharmacoeconomics200826866167718620460
  • Reed JohnsonFLancsarEMarshallDConstructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task ForceValue Health201316131323337210
  • RyanGWWagnerGJPill taking “routinization”: a critical factor to understanding episodic medication adherenceAIDS Care200315679580614617501
  • PearmainDSwansonJKroesEBradleyMStated Preference Techniques: A Guide to Practice2nd edThe HagueSteer Davies Gleave and Hague Consulting Group1991
  • RothmanMBurkeLEricksonPLeidyNKPatrickDLPetrieCDUse of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force reportValue Health20091281075108319804437
  • Guidance for IndustryPatient-Reported Outcome Measures: use in medical product development to support labelling claims2009 Available from: www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdfAccessed April 11, 2016
  • GibbsGAnalyzing Qualitative Data (Qualitative Research Kit)London, USASage2007
  • KerrCNixonAWildDAssessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes researchExpert Rev Pharmacoecon Outcomes Res201010326928120545592
  • GlaserBStraussAThe Discovery of Grounded Theory: Strategies for Qualitative ResearchChicago, ILAldine Publishing Company1967
  • SchoutenJWitFWStolteIGCross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort studyClin Infect Dis201459121787179725182245
  • SmitMBrinkmanKGeerlingsSFuture challenges for clinical care of an ageing population infected with HIV: a modelling studyLancet Infect Dis201515781081826070969
  • MühlbacherACStollMMahlichJNüblingMPatient preferences for HIV/AIDS therapy – a discrete choice experimentHealth Econ Rev2013311423663390
  • Dray-SpiraRMAubrièreCMarcellinFHealth status of people living with HIV followed at hospital in metropolitan France in 2011 and characteristics of those recently diagnosed. Results of the ANRSVESPA2 Study. Bulletin épidémiologique hebdomadaire n°26–27 du 2 juillet 2013 Available from: http://invs.santepubliquefrance.fr//beh/2013/27/2013_26-27_1.htmlAccessed July 20, 2015